Bristol Myers Squibb reported $44.74B in Debt for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
ALKERMES ALKS:US $ 296.44M 0.63M
Amgen AMGN:US $ 37579M 4797M
AstraZeneca AZN:LN 31912M 4417M
Astrazeneca AZN:US $ 31912M 4417M
Biogen BIIB:US $ 7271.1M 1.9M
Bristol Myers Squibb BMY:US $ 44742M 416M
Catalent CTLT:US $ 4304M 1063M
Coherus Biosciences CHRS:US $ 407.17M 1.09M
Drreddys Laboratories RDY:US $ 30273M 3100M
Eli Lilly And LLY:US $ 17085.4M 570.3M
Endo International Ordinary Shares ENDP:US $ 8300.6M 3.52M
GlaxoSmithKline GSK:LN 25605M 122M
Gw Pharmaceuticals GWPH:US $ 15.19M 0.11M
Horizon Pharma HZNP:US $ 2573.86M 2.58M
Intercept Pharmaceuticals ICPT:US $ 530.4M 45.42M
JAZZ PHA JAZZ:US $ 6285.05M 459.25M
Lannett LCI:US $ 596.98M 6.29M
Medtronic MDT:US $ 25623M 341M
Novartis NOVN:VX SF 34243M 1526M
Perrigo Ordinary Shares PRGO:US $ 3550.3M 5.6M
Phibro Animal Health PAHC:US $ 405.26M 13.18M
Prestige Brands PBH:US $ 1607.1M 52.98M
Regeneron Pharmaceuticals REGN:US $ 2698.6M 1M
Revance Therapeutics RVNC:US $ 280.32M 0.32M
Teva Pharmaceutical Industries TEVA:US $ 23746M 1386M
United Therapeutics UTHR:US $ 800M 0M
Zoetis ZTS:US $ 6592M 604M